Together, these studies position CHROMR as a central regulator of DLBCL proliferation, where elevated CHROMR levels enhance the expression of proliferation-associated genes such as CNNM1 and MET by sequestering their regulatory miRNAs. The gene discussed is MET; the disease is diffuse large B-cell lymphoma.